EQ-318

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEQ-318
Drug Alias NameNS5B polymerase inhibitor (Equispharm)EQ-318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreaPlanet Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreaPlanet Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A